sotrovimab

<!-- Name:DistributionId Value:8754497 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the US Food and Drug Administration has amended the Emergency Use Authorization (EUA)…

The FDA on Wednesday quietly limited the use of another monoclonal antibody for COVID-19 after data showed considerably lower neutralization…

– Pseudovirus results being shared with government and regulatory authorities;publication in bioRxiv anticipated in the coming week; additional live virus testing underway – SAN FRANCISCO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Vir…

According to a statement issued by the WHO on January 14, Baricitinib is recommended for treating patients suffering with severe or critical Covid-19. On the other hand, Sotrovimab, a monoclonal antibody drug, is recommended for treating…

Covid-19 drugs Baricitinib, which is currently used to treat rheumatoid arthritis, has now been strongly recommended for Coronavirus patients who are suffering from extremely severe Coronavirus. The drug is to be administered along with…

–  Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – – Together with recent pseudo- and live virus results, additional preclinical data reinforce sotrovimab retains in vitro…

Note that some links may require registration or subscription. NIAID Director Anthony Fauci, MD, said the federal government should consider…

LONDON and SAN FRANCISCO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the European Commission (EC) has granted marketing authorization to Xevudy…

 – Preclinical data demonstrate sotrovimab, authorized in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron – – Data to be confirmed by further in vitro…